VONOPRAZAN- VERSUS PROTON-PUMP INHIBITOR-BASED THIRD-LINE 7-DAY SITAFLOXACIN-CONTAINING TRIPLE THERAPY FOR HELICOBACTER PYLORI: A PROSPECTIVE, RANDOMIZED TRIAL

被引：0
|
作者：
Sue, Soichiro
Shibata, Wataru
Kaneko, Hiroaki
Irie, Kuniyasu
Sasaki, Tomohiko
Kondo, Masaaki
Maeda, Shin
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1302
引用
收藏
页码：S927 / S928
页数：2
相关论文
共 50 条
  • [21] Comparison of Vonoprazan and Amoxicillin Dual Therapy with Standard Triple Therapy with Proton Pump Inhibitor for Helicobacter Pylori eradication: A Randomized Control Trial
    Zuberi, Bader Faiyaz
    Ali, Faiza Sadaqat
    Rasheed, Tazeen
    Bader, Nimrah
    Hussain, Sana Muhammad
    Saleem, Anoshia
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (04) : 965 - 969
  • [22] Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysis
    Li, Bo
    Lan, Xiaoqian
    Wang, Li
    Zhao, Jiani
    Ding, Jingli
    Ding, Hao
    Lei, Jun
    Wei, Yiping
    Zhang, Wenxiong
    MICROBIAL PATHOGENESIS, 2020, 142
  • [23] Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy:: A detailed, prospective analysis of 21 consecutive cases
    Gomollón, F
    Ducóns, JA
    Ferrero, M
    Cabezudo, JG
    Guirao, R
    Simón, MA
    Montoro, M
    HELICOBACTER, 1999, 4 (04) : 222 - 225
  • [24] Effect of additional ecabet sodium on conventional proton-pump inhibitor-based triple therapy for Helicobacter pylori (H. pylori) eradication in Korea
    Kim, Ji Y.
    Lee, Dong H.
    Park, Young S.
    Kim, Nayoung
    Jung, Hyun C.
    Song, In S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A165 - A165
  • [25] Ten-day vonoprazan-based versus fourteen-day proton pump inhibitor-based therapy for first-line Helicobacter pylori eradication in China: A meta-analysis of randomized controlled trials
    Gao, Wenwen
    Wang, Qian
    Zhang, Xiang
    Wang, Lu
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2024, 38
  • [26] Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan
    Howden, Colin W. W.
    Cook, Erin E. E.
    Swallow, Elyse
    Yang, Karen
    Guo, Helen
    Pelletier, Corey
    Jacob, Rinu
    Sugano, Kentaro
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [27] EFFICACY OF 7-DAY AND 10-DAY OF VAB (VONOPRAZAN, AMOXICILLIN, AND BISMUTH SUBSALICYLATE) VERSUS 14-DAY STANDARD TRIPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
    Phetkee, Thitiwat
    Anansawat, Veerayut
    Suksamai, Anuchit
    Songserm, Sukhum
    Yongwatana, Kachonsak
    GASTROENTEROLOGY, 2023, 164 (06) : S375 - S376
  • [28] Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials
    Chen, Po-Yueh
    Tsai, Feng-Pai
    Chen, Mei-Jyh
    Yang, Hsin-Yi
    Wu, Ming-Shiang
    Liou, Jyh-Ming
    GUT, 2023,
  • [29] Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure
    Mak, SK
    Loo, CK
    Wong, AMC
    Wong, PN
    Lo, KY
    Tong, GMW
    Lam, EKM
    Wong, AKM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (03) : 576 - 581
  • [30] Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea
    Kim, Y. S.
    Kim, S. J.
    Yoon, J. H.
    Suk, K. T.
    Kim, J. B.
    Kim, D. J.
    Kim, D. Y.
    Min, H. J.
    Park, S. H.
    Shin, W. G.
    Kim, K. H.
    Kim, H. Y.
    Baik, G. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (09) : 1098 - 1105
12345